United States · FDA National Drug Code directory
BIMATOPROST
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 42571-128_22ffbe26-763a-a793-e063-6394a90a6027
- Product NDC
- 42571-128
- Form
- SOLUTION/ DROPS
- Composition / generic term
- BIMATOPROST
- Labeler
- Micro Labs Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210315
- Source listing expiry
- 20261231
Source-listed ingredients
- BIMATOPROST — .3 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (42571-128-21) / 5 mL in 1 BOTTLE · 42571-128-21
- 1 BOTTLE in 1 CARTON (42571-128-28) / 7.5 mL in 1 BOTTLE · 42571-128-28
- 1 BOTTLE in 1 CARTON (42571-128-35) / 2.5 mL in 1 BOTTLE · 42571-128-35
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →